Clinical Trial Update: Randomized Study Of Sunitinib Plus FOLFOX Versus Bevacizumab Plus FOLFOX In Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 randomized study comparing Sunitinib plus FOLFOX versus Bevacizumab plus FOLFOX in metastatic colorectal cancer was terminated, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFOX regimen (folinic acid (leucovorin) + fluorouracil + oxaliplatin)
• Sunitinib (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Colorectal Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2012-10-11